Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In clinical studies, GLP-1 administered intravenously to fasting patients failed to reduce blood sugar levels compared with patients who consumed a meal
Key highlights GLP-1 medications such as Ozempic, Wegovy, and Mounjaro can cost $800-$1,300 per month without insurance coverage, making them unaffordable for many patients
Description BPC157: Synthetic Peptide for Research Use BPC157 (Body Protection Compound157) is a synthetic peptide consisting of 15 amino acids , derived from a sequence found in gastric proteins
Chronically elevated blood sugar reacts with enzymes and other protein molecules to create advanced glycation end-products (AGEs)
US$ 20.10
US$ 28.73
US$ 26.89
US$ 27.78
US$ 24.90
US$ 28.24
US$ 29.94
US$ 22.83
